Priyatham Kasaraneni

2PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Jan 09, 2024
2/1 dose schedule of sunitinib is superior than the 4/2 regimen for the first-line therapy of clear cell metastatic renal cell carcinoma - An Indian experience.

Jiten Jaipuria, Ankita Jain, Shashikant Gupta

|Nov 15, 2019
Stepwise approach in the management of penile strangulation and penile preservation: 15-year experience in a tertiary care hospital.

Sandeep Puvvada, Priyatham Kasaraneni, Ramesh Desi Gowda

Pageof 1

Frequent Collaborators

1 joint publications

Sandeep Puvvada

1 joint publications

Jiten Jaipuria

1 joint publications

Ankita Jain

1 joint publications

Shashikant Gupta